Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Gene delivery

April 27, 2026 CD derivatives / Drug delivery / Gene delivery / Pharma applications

Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery

This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems

Continue reading

November 17, 2025 CD as API / Pharma applications

Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients

Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that

Continue reading

October 25, 2024 Gene delivery / Pharma applications

β-Cyclodextrin-based geometrically frustrated amphiphiles as one-component, cell-specific and organ-specific nucleic acid delivery systems

Here a new βCD-based nucleic acid delivery platform is proposed that surmounts the former archetype in its capacity to encode

Continue reading

August 22, 2024 Gene delivery / Pharma applications

Synthesis, characterization, and application of a biocompatible gene delivery nanocarrier constructed from gold nanostars and a chitosan–cyclodextrin–poly(ethylene imine) graft polymer

Gene therapy can be an efficient method to treat genetic diseases, including cancer. However, the lack of biocompatible gene delivery

Continue reading

July 26, 2024 CD derivatives / Drug delivery / Pharma applications

Codelivery of Doxorubicin and p53 Gene by β-Cyclodextrin-Based Supramolecular Nanoparticles

A supramolecular system was developed for codelivery of doxorubicin (Dox) and p53 gene based on a β-CD-containing star-shaped cationic polymer.

Continue reading

June 18, 2024 Drug delivery / Pharma applications

Cationic cycloamylose based nucleic acid nanocarriers

Nucleic acid delivery by viral and non-viral methods has been a cornerstone for the contemporary gene therapy aimed at correcting

Continue reading

March 15, 2024 Drug delivery / Gene delivery / Pharma applications

Special issue: Cyclodextrin-Based Gene and Drug Delivery Applications

This Special Issue aims to showcase cutting-edge research, advancements, and applications of cyclodextrin-based delivery systems in the context of gene

Continue reading

August 15, 2023 CD derivatives / Drug delivery / Gene delivery / Pharma applications / Uncategorized

Cyclodextrins as eminent constituents in nanoarchitectonics for drug delivery systems.

Cyclodextrins have been widely employed for drug delivery systems (DDSs) in which drugs are selectively delivered to a target site

Continue reading

August 2, 2023 CD derivatives / Gene delivery / Other industrial use / Pharma applications

Special Issue “Nucleic Acids Chemistry: A Special Issue Celebrating the 75th Birthday of Prof. Makoto Komiyama”

Professor Makoto Komiyama (born in 1947) is a world-famous nucleic acid chemist who is known for using artificial approaches to

Continue reading

August 5, 2022 Drug delivery / Gene delivery / Pharma applications

Special Issue: Supramolecular Systems for Gene and Drug Delivery (Volume II) 

Special Issue: Supramolecular Systems for Gene and Drug Delivery (Volume II) has been anounced in the journal Pharmaceutics which has just

Continue reading

Posts pagination

1 2 3 Next Posts»

Recent Posts

  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (356)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,220)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Association of Sugammadex Exposure with Venous Thrombosis Risk Following Primary Total Knee Arthroplasty: A Multi-Institutional Retrospective Analysis
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Two ways for manufacturing CD fibres
  • Revolutionary Nanozyme Microneedles for Gout Treatment
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Beyond Cholesterol: New Review Examines 7-Ketocholesterol and Its Role in Disease
  • Japanese Breakthrough Science: Enzyme-Degradable Recyclable Plastic Reinforced with Movable Cyclodextrin Crosslinks
  • Strategies against antifungal resistance

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...